Genomma Lab InternacionalB de CV (MEX:LABB) Days Sales Outstanding : 92.36 (As of Jun. 2024)

View and export this data going back to 2008. Start your Free Trial

What is Genomma Lab InternacionalB de CV Days Sales Outstanding?

Genomma Lab InternacionalB de CV's average Accounts Receivable for the three months ended in Jun. 2024 was MXN4,708 Mil. Genomma Lab InternacionalB de CV's Revenue for the three months ended in Jun. 2024 was MXN4,651 Mil. Hence, Genomma Lab InternacionalB de CV's Days Sales Outstanding for the three months ended in Jun. 2024 was 92.36.

The historical rank and industry rank for Genomma Lab InternacionalB de CV's Days Sales Outstanding or its related term are showing as below:

MEX:LABB' s Days Sales Outstanding Range Over the Past 10 Years
Min: 80.9 Med: 97.8 Max: 146.64
Current: 95.79

During the past 13 years, Genomma Lab InternacionalB de CV's highest Days Sales Outstanding was 146.64. The lowest was 80.90. And the median was 97.80.

MEX:LABB's Days Sales Outstanding is ranked worse than
71.44% of 984 companies
in the Drug Manufacturers industry
Industry Median: 71.41 vs MEX:LABB: 95.79

Genomma Lab InternacionalB de CV's Days Sales Outstanding declined from Jun. 2023 (93.71) to Jun. 2024 (92.36).

Genomma Lab InternacionalB de CV Days Sales Outstanding Historical Data

The historical data trend for Genomma Lab InternacionalB de CV's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genomma Lab InternacionalB de CV Days Sales Outstanding Chart

Genomma Lab InternacionalB de CV Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Sales Outstanding

Get a 7-Day Free Trial

124.91

98.25

97.34

92.27

88.81

Genomma Lab InternacionalB de CV Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
Days Sales Outstanding	Get a 7-Day Free Trial															93.71	91.84	104.16	90.41	92.36

Competitive Comparison of Genomma Lab InternacionalB de CV's Days Sales Outstanding

For the Drug Manufacturers - Specialty & Generic subindustry, Genomma Lab InternacionalB de CV's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Genomma Lab InternacionalB de CV's Days Sales Outstanding Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Genomma Lab InternacionalB de CV's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Genomma Lab InternacionalB de CV's Days Sales Outstanding falls into.

Genomma Lab InternacionalB de CV Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Genomma Lab InternacionalB de CV's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

	Days Sales Outstanding (A: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (4270.528	+	3743.154)	/	2 )	/	16467.126	*	365
=	4006.841					/	16467.126	*	365
=	88.81

Genomma Lab InternacionalB de CV's Days Sales Outstanding for the quarter that ended in Jun. 2024 is calculated as:

	Days Sales Outstanding (Q: Jun. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Mar. 2024 )	+	Accounts Receivable (A: Jun. 2024 ))	/	count )	/	Revenue (A: Jun. 2024 )	*	Days in Period
=	( (4574.302	+	4842.027)	/	2 )	/	4651.495	*	365 / 4
=	4708.1645					/	4651.495	*	365 / 4
=	92.36

Genomma Lab InternacionalB de CV (MEX:LABB) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Genomma Lab InternacionalB de CV Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Genomma Lab InternacionalB de CV's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Genomma Lab InternacionalB de CV Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Genomma Lab Internacional SAB de CV (MEX:LABB) » Definitions » Days Sales Outstanding

Traded in Other Exchanges

GNMLF:USA

Address

Avenida Antonio Dovali Jaime, Number 70, Tower C, Floor 2, Office A. Colonia Santa Fe, Del. Alvaro Obregon, Mexico, MEX, MEX, CP 01210

Website

https://www.genommalab.com

Genomma Lab Internacional SAB de CV is a specialty and generic drug manufacturer. The company's stated goal is to improve and preserve the health and well-being of people through innovative, safe, and effective products. Genomma operates a wide variety of brands to serve different consumer needs, including pregnancy, pain medication, and deodorant. The company considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.

Genomma Lab InternacionalB de CV Headlines

No Headlines